This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dynavax Technologies Corp
DVAX : NASDAQ : Health Care
$1.42 -0.00 | -0.35%
Today's Range: 1.41 - 1.45
Avg. Daily Volume: 1,781,400
09/02/14 - 10:12 AM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
DVAX DYNAVAX TECHNOLOGIES CORP 1.38 362.78 n/m 12.32 21.29
VNDA VANDA PHARMACEUTICALS INC 12.36 418.73 n/m 37.50 15.03
CTIC CTI BIOPHARMA CORP 2.55 382.33 n/m 36.00 2413.96
PGNX PROGENICS PHARMACEUTICAL INC 5.30 368.65 n/m 7.13 -49.20
GERN GERON CORP 2.33 365.54 n/m 1.22 -44.56
RTRX RETROPHIN INC 13.60 362.88 n/m 5.77 n/a
CUR NEURALSTEM INC 4.01 348.22 n/m 0.01 -94.99
RNA PROSENSA HOLDING NV 9.15 330.28 n/m 28.16 954.21
TGTX TG THERAPEUTICS INC 8.55 325.93 n/m 0.15 60.00
ZIOP ZIOPHARM ONCOLOGY INC 3.15 317.34 n/m 0.80 0.00
PPHM PEREGRINE PHARMACEUTICLS INC 1.65 314.71 n/m 22.40 3.31
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

DVAX Ind Avg S&P 500
n/m 84.51 19.80

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs